Padcev Plus Keytruda Is ‘Exciting’ for Chemo-Ineligible Bladder Cancer
May 10th 2023The recent FDA approval of Padcev plus Keytruda for locally advanced/metastatic, chemotherapy-ineligible bladder cancer offers an “exciting opportunity” for this difficult-to-treat patient population, an expert said.
Read More
Evaluating Existing and Future Surgical Options for Early-Stage Lung Cancer
November 23rd 2022As part of its “Speaking Out” video series, Dr. Peter Baik, on behalf of Cancer Treatment Centers of America, discussed how far the space has come with surgical advances, and where it is headed, in treating early-stage lung cancer.
Watch
Oncology Rehabilitation: An Integral Part of Integrative Care for Head and Neck Cancer Treatment
May 26th 2022Head and neck cancer treatments and the subsequent side effects can be overwhelming for patients and their caregivers due to the impact they have on routine activities, writes a speech-language pathologist at Cancer Treatment Center of America Atlanta. However, the expert notes, there are plenty of specialists who can help improve patient quality of life.
Read More
Advancements in Rare Blood Cancer Have ‘Changed the Way We Treat Every Cancer’, Expert Says
February 11th 2022A blood cancer specialist discusses how the development of tyrosine kinase inhibitors in the 1990s to treat chronic myelogenous leukemia drove major oncology advancements over the next three decades.
Read More